Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimers disease in people with Type 2 diabetes, according to a study published Thursday in the journal Alzheimers & Dementia
I did want someone to be a backup plan
Dosovitskiy, A., Beyer, L., Kolesnikov, A., Weissenborn, D., Zhai, X., Unterthiner, T., Dehghani, M., Minderer, M., Heigold, G., Gelly, S., Uszkoreit, J
Eat slowly and stop when satisfied, not full
Wegovy is a brand-name semaglutide product FDA-approved for chronic weight management in eligible patients, while Ozempic is a brand-name semaglutide product FDA-approved for type 2 diabetes and certain related risk-reduction indications
Food and Drug Administration (FDA) do not monitor the safety or effectiveness of supplements, so it is important to choose a reputable brand